Glen Harbor Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Glen Harbor Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$11M	Buy	85,884 +10,098	+13%	+$1.35M	0.23%	88
2019 Q2	$10.8M	Buy	75,786 +4,692	+7%	+$631K	0.23%	92
2019 Q1	$10.2M	Buy	71,094 +28,968	+69%	+$3.78M	0.22%	102
2018 Q4	$5.22M	Buy	42,126 +39,950	+1,836%	+$5.93M	0.13%	174
2018 Q3	$366K	Buy	2,176 +1,904	+700%	+$327K	0.01%	840
2018 Q2	$47K	Buy	+272	New	+$44.5K	﹤0.01%	1221

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Glen Harbor Capital Management's JAZZ Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q3 2019, buying an estimated $1.35M and bringing the position to 85,884 shares worth $11M. The position accounts for 0.23% of the portfolio, ranked #88.

Glen Harbor Capital Management first reported a position in JAZZ in Q2 2018 and has held it in 6 quarters since. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

Glen Harbor Capital Management held 85,884 shares of Jazz Pharmaceuticals worth $11M as of Q3 2019.
Glen Harbor Capital Management bought 10,098 Jazz Pharmaceuticals shares in Q3 2019, an estimated $1.35M.
Jazz Pharmaceuticals made up 0.23% of Glen Harbor Capital Management's portfolio in Q3 2019, its #88 holding.
Glen Harbor Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 6 quarters since.
406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.